| ²é¿´: 840 | »Ø¸´: 3 | |||||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||||
idlerenͳæ (СÓÐÃûÆø)
|
[½»Á÷]
ҽѧ·Ö×Ó²¡¶¾Ñ§ÀíÂÛ¿Î
|
||||
|
¹Û¿´µØÖ· http://mvlab-fudan.cn/xxyd/hhh9.htm ¡¡ ÄÚÈݰüÀ¨£º ҽѧ·Ö×Ó²¡¶¾Ñ§ÀíÂۿογ̱í.pdf 1.²¡¶¾Ñ§ÃæÁÙµÄÌôÕ½:ÐÂÏÖºÍÔÙÏÖ²¡¶¾¸ÐȾ(ÎÅÓñ÷Ժʿ) £¨1£©¿Î¼þ/molecular virology 2.²¡¶¾½á¹¹¡¢ºËËáºÍµ°°×£¨Ô¬Õýºê£© £¨1£©¿Î¼þ/virus cultivation, detection and genetics £¨2£©¿Î¼þ/Viral Structure £¨3£©²Î¿¼ÍøÒ³/Microbiology and immunology on-line £¨4£©²Î¿¼ÍøÒ³/Immunology Overview 3.²¡¶¾¸´ÖƼ°Óëϸ°ûÏ໥×÷Óã¨Ô¬Õýºê£© £¨1£©¿Î¼þ/Viral replication and interaction with host cells 4.¿¹²¡¶¾¸ÐȾÃâÒߣ¨öĵӣ© £¨1£©¿Î¼þ/anti-viral 5.²¡¶¾³ÖÐøÐÔ¸ÐȾµÄ»úÖÆ£¨öĵӣ© £¨1£©¿Î¼þ/Viral Persistent Infection 6.¿¹²¡¶¾ÖƼÁ(ÍõÓÂÏè) £¨1£©¿Î¼þ/Antiviral Agents 7.·Ö×Ó²¡¶¾Ñ§Õï¶ÏµÄ¼¼ÊõºÍÔÀí(ºúÜ¿ÎÄ) £¨1£©¿Î¼þ/¸ÎÑײ¡¶¾ºËËáµÄ·Ö×ÓÉúÎïѧ¼ì²â·½·¨ºÍÓ¦Óà 8.²¡¶¾ÒßÃçÑо¿µÄÏÖ×´ÓëδÀ´£¨öĵӣ© £¨1£©¿Î¼þ/vaccine 9.²¡¶¾ÓëÖ×Áö£¨öĵӣ© £¨1£©¿Î¼þ/virus-tumor 10.³¦µÀ²¡¶¾£¨Íõ¼Ò¶°£© £¨1£©¿Î¼þ/Enteroviruses 11.¸ÎÑײ¡¶¾£¨Í¯ÎÄÑࣩ £¨1£©¿Î¼þ/Hepatitis Virus 12.Á÷¸Ð²¡¶¾¡¢SARS²¡¶¾µÈºôÎüµÀ¸ÐȾ²¡¶¾£¨Ðí±ó£© £¨1£©¿Î¼þ/Á÷¸Ð²¡¶¾ÓëSARS 13.ÈËÐ󹲸ÐȾµÄ΢ÉúÎïºÍÉúÎïÕ½µÄ·ÀÓù£¨ÅËÎÀ£© £¨1£©¿Î¼þ/ÉúÎïÎäÆ÷ºÍÉúÎï·ÀÓù 14.²¡ÔÉúÎïµÄ¿¹Ì幤³Ì£¨³Ìѵ¼Ñ£© £¨1£©¿Î¼þ/monoclonal antibody 15.HIV²¡¶¾Ñ§ºÍHIVÒßÃç(¬ºéÖÞ) £¨1£©¿Î¼þ/Aids 16.²¡¶¾·Ö×ÓÁ÷Ðв¡Ñ§Ñо¿(Ðìì®) £¨1£©¿Î¼þ/Introduction to Molecular Epidemiology |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
²Î¿¼Êé¼® | ÎÒµÄÐÂÁìÓò |
» ²ÂÄãϲ»¶
271Çóµ÷¼Á
ÒѾÓÐ30È˻ظ´
²ÄÁÏÀà284µ÷¼Á
ÒѾÓÐ50È˻ظ´
291·Öµ÷¼Á
ÒѾÓÐ9È˻ظ´
µ÷¼ÁÇóÊÕÁô
ÒѾÓÐ34È˻ظ´
291 Çóµ÷¼Á
ÒѾÓÐ38È˻ظ´
22408 312Çóµ÷¼Á
ÒѾÓÐ17È˻ظ´
Ò»Ö¾Ô¸»ªÖÐũҵ071010£¬320Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
290µ÷¼ÁÉúÎï0860
ÒѾÓÐ41È˻ظ´
291Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
211±¾¿Æ²ÄÁÏ»¯¹¤Çóµ÷¼Á
ÒѾÓÐ23È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
1
|
2Â¥2006-08-17 17:08:13
luyunxia0514
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1422
- ºì»¨: 1
- Ìû×Ó: 327
- ÔÚÏß: 16.7Сʱ
- ³æºÅ: 215901
- ×¢²á: 2006-03-11
- רҵ: ÌÇÄò²¡
3Â¥2006-08-17 20:57:40
idleren
ͳæ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 99.5
- Ìû×Ó: 55
- ÔÚÏß: 54·ÖÖÓ
- ³æºÅ: 153523
- ×¢²á: 2006-01-02
- רҵ: ÉúÎï
4Â¥2006-08-17 22:30:43














»Ø¸´´ËÂ¥

